首页> 外文期刊>International journal of toxicology >In vivo prevention of bladder urotoxicity: purified hydroxytyrosol ameliorates urotoxic effects of cyclophosphamide and buthionine sulfoximine in mice.
【24h】

In vivo prevention of bladder urotoxicity: purified hydroxytyrosol ameliorates urotoxic effects of cyclophosphamide and buthionine sulfoximine in mice.

机译:体内预防膀胱尿毒毒性:纯化的羟基替糖醇改善了环磷酰胺和苯胺磺酰胺在小鼠中的致尿毒毒性作用。

获取原文
获取原文并翻译 | 示例
       

摘要

Urotoxicity is a troublesome complication associated with cyclophosphamide (CP) and L-buthionine-SR-sulfoximine (BSO) treatment in chemotherapy. With this concern in mind, the present study investigated the potential effects of a hydroxytyrosol extract from olive mill waste (OMW) on urotoxicity induced by acute CP and BSO doses using a Swiss albino mouse model. Toxicity modulation was evaluated by measuring lipid peroxidation (LPO) and antioxidants in urinary bladder. The findings revealed that the hydroxytyrosol extract exerted a protective effect not only on LPO but also on enzymatic antioxidants. When compared to the controls, the CP-treated animals underwent significant decreases in the glutathione S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GP), and catalase (CAT) activities. The level of glutathione (GSH) was also reduced with increased doses of LPO in the CP-treated animals. L-Buthionine-SR-sulfoximine treatment exerted an additive toxic effect on the CP-treated animals. Interestingly, pretreatment with the hydroxytyrosol extract restored the activities of all enzymes back to normal levels and exhibited an overall protective effect on the CP- and BSO-induced toxicities in urinary bladder. The restoration of GSH through the treatment with the hydroxytyrosol extract can play an important role in reversing CP-induced apoptosis and free radical-mediated LPO.
机译:致尿毒性是一种麻烦的并发症,其与环磷酰胺(CP)和L-苯胺 - SR-磺酰胺(BSO)处理相关的化疗。通过考虑到这项担忧,本研究研究了使用瑞士白化小鼠模型对由急性CP和BSO剂量诱导的尿血液碾压(OMW)对尿毒性诱导的尿毒性的潜在影响。通过测量脂质过氧化(LPO)和膀胱中的抗氧化剂来评估毒性调节。结果表明,羟基吡咯醇提取物不仅在LPO上施加保护效果,还施加在酶促抗氧化剂上。与对照相比,CP处理的动物在谷胱甘肽S-转移酶(GST),谷胱甘肽还原酶(GR),谷胱甘肽过氧化物酶(GP)和过氧化氢酶(猫)活性下进行显着降低。通过增加CP处理的动物剂量增加的LPO,还减少了谷胱甘肽(GSH)的水平。 L-Buthionine-Sr-磺酰昔胺治疗对CP处理的动物进行了添加剂毒性作用。有趣的是,用羟基替斯洛尔提取物的预处理将所有酶的活动恢复到正常水平,并对尿膀胱中的CP和BSO诱导的毒性表现出总体保护作用。通过用羟基羟基溶胶提取物的处理恢复GSH可以在逆转CP诱导的凋亡和自由基介导的LPO中发挥重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号